血浆内司他丁是重症监护中急性肾损伤和肾脏替代疗法需求的早期肌酐独立预测因子

medRxiv - Intensive Care and Critical Care Medicine Pub Date : 2024-04-26 DOI:10.1101/2024.04.25.24306345

Hazem Koozi, Jonas Engström, Martin Spångfors, Hans Friberg, Attila Frigyesi

{"title":"血浆内司他丁是重症监护中急性肾损伤和肾脏替代疗法需求的早期肌酐独立预测因子","authors":"Hazem Koozi, Jonas Engström, Martin Spångfors, Hans Friberg, Attila Frigyesi","doi":"10.1101/2024.04.25.24306345","DOIUrl":null,"url":null,"abstract":"<strong>Purpose</strong> Endostatin is a promising biomarker for predicting acute kidney injury (AKI) and mortality in the intensive care unit (ICU). We investigated plasma endostatin upon ICU admission as a predictor of AKI, renal replacement therapy (RRT), and 30-day mortality.","PeriodicalId":501249,"journal":{"name":"medRxiv - Intensive Care and Critical Care Medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Plasma endostatin is an early creatinine independent predictor of acute kidney injury and need for renal replacement therapy in critical care\",\"authors\":\"Hazem Koozi, Jonas Engström, Martin Spångfors, Hans Friberg, Attila Frigyesi\",\"doi\":\"10.1101/2024.04.25.24306345\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<strong>Purpose</strong> Endostatin is a promising biomarker for predicting acute kidney injury (AKI) and mortality in the intensive care unit (ICU). We investigated plasma endostatin upon ICU admission as a predictor of AKI, renal replacement therapy (RRT), and 30-day mortality.\",\"PeriodicalId\":501249,\"journal\":{\"name\":\"medRxiv - Intensive Care and Critical Care Medicine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-04-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"medRxiv - Intensive Care and Critical Care Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1101/2024.04.25.24306345\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"medRxiv - Intensive Care and Critical Care Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2024.04.25.24306345","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

目的内司他丁是预测重症监护病房（ICU）急性肾损伤（AKI）和死亡率的一种有前途的生物标志物。我们研究了 ICU 入院时血浆内司他丁作为 AKI、肾脏替代治疗（RRT）和 30 天死亡率的预测因子。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Plasma endostatin is an early creatinine independent predictor of acute kidney injury and need for renal replacement therapy in critical care

Purpose Endostatin is a promising biomarker for predicting acute kidney injury (AKI) and mortality in the intensive care unit (ICU). We investigated plasma endostatin upon ICU admission as a predictor of AKI, renal replacement therapy (RRT), and 30-day mortality.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

medRxiv - Intensive Care and Critical Care Medicine

自引率

0.00%

发文量